Miraca Life Sciences Revenue and Competitors

Inform Diagnostics, previously known as Miraca Life Sciences serves more than 5,500 patients each day, providing expert pathology services in the fields of dermatopathology, breast pathology, GI pathology, hematology/oncology pathology, and urologic pathology. Additionally, Miraca provides health IT consulting services, and has helped hundreds of practices with programs such as MIPS, quality reporting, Meaningful Use, security risk assessments, and HIPAA compliance.\n\nThe company, previously known as Caris Diagnostics, was renamed Miraca Life Sciences in February 2012. In November 2017, Miraca Life Sciences was acquired by Avista Capital Partners.\n\nAs a leader in anatomic pathology, Inform Diagnostics combines the rigor of an academic medical institution with the innovative spirit of a technology company.\n\nBy working for Inform Diagnostics, you will have the opportunity to contribute alongside top multidisciplinary talented professionals, who are dedicated to meeting the needs of our clinician clients and their patients. You will work in a state-of-the-art environment with cutting-edge tools, breakthrough technologies and with world-renowned thought leaders. The company utilizes a forward-thinking business model seeking to make a profound difference in the quality of care for patients.